Ascendia Pharmaceutical Solutions will exhibit at the 15th Annual Partnership Opportunities in Drug Delivery (PODD) Conference, taking place October 27–28, 2025, in Boston, Massachusetts. Attendees can connect with Ascendia Pharmaceutical Solutions at Booth #116 to explore innovative formulation and delivery technologies designed to enhance drug solubility, bioavailability, and therapeutic performance.
Expertise in Complex Drug Delivery Systems
At PODD 2025, Ascendia Pharmaceutical Solutions will highlight its integrated capabilities in nanoparticle formulations, lipid-based systems, and long-acting injectables. These technologies support the development of novel and optimized drug products across small molecules, peptides, and biologics. The company’s formulation scientists and development teams partner with pharmaceutical and biotech clients to address complex solubility and stability challenges, efficiently and reliably advancing molecules from concept to clinic.
Featured Presentation: LipidSol® Technology for Small Molecules and Biologics
Ascendia Pharmaceutical Solutions’ Senior Director of Scientific Affairs & Technical Marketing, Dr. Shaukat Ali, will present during the “Cell, Gene & Novel Biologics Delivery” track on October 27 at 2:25 p.m. in the America Ballroom Center (Track 2A). His presentation, titled “LipidSol® – An Enabler for Delivery of Small Molecules and Biologics,” will examine how the LipidSol® platform enhances solubility and bioavailability for challenging compounds. Attendees will gain insights into the application of lipid-based delivery technologies that support both small-molecule and biologic drug programs.
A Partner for Drug Delivery Innovation
PODD 2025 brings together leaders focused on emerging drug delivery technologies and strategic collaboration opportunities. Ascendia Pharmaceutical Solutions invites companies evaluating formulation approaches or seeking CDMO partners to visit Booth #116. The team will be available to discuss how its formulation expertise and development infrastructure can advance drug candidates with improved performance and patient compliance.
Meet Ascendia Pharmaceutical Solutions at PODD 2025
Companies attending PODD 2025 are encouraged to schedule a meeting with Dr. Shaukat Ali, Rhonda Baker, or Jack Keily to discuss partnership opportunities and customized formulation solutions. Click here to reserve your meeting time in advance.
Register for PODD 2025 and Save 10%
Join Ascendia Pharmaceutical Solutions in Boston for PODD 2025. Register through the PODD conference website and receive a 10% discount with the code ASCENDIA10.